Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Faculty Members have conducted research related to the Regorafenib Versus Cetuximab Plus Irinotecan in Third-Line Metastatic Colorectal Cancer in Iran: A Model-Based Cost-Utility Analysis
Zahra Jahangard-Rafsanjani
Zahra Jahangard-Rafsanjani

Associate Professor of Clinical Pharmacy

Department Clinical Pharmacy

School of Pharmacy

Tehran University of Medical Sciences

All Documents